[1] 王爱平, 孙毅, 涂平, 等. 伊曲康唑联合特比萘芬治愈着色芽生菌病1例[J]. 中国真菌学杂志, 2012, 7(3):161-162. [2] Xi L, Sun J, Lu C, et al. Molecular diversity of Fonsecaea(Chaetothyriales)causing chromoblastomycosis in southern China[J]. Med Mycol, 2009, 47(1):27-33. [3] 赵作涛, 鲁巧云, 高那, 等. 首次报道中国北方Fonsecaea monophora所致着色芽生菌病1例及其相关实验研究[J].中国真菌学杂志, 2010, 5(4):193-195. [4] National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard[S]. NCCLS document M38-A. NCCLS, Wayne, Pa, USA, 2002. [5] De Hoog GS, Attili-Angelis D, Vicente VA, et al. Molecular ecology and pathogenic potential of Fonsecaea species[J]. Med Mycol, 2004, 42(5): 405-416. [6] Surash S, Tyagi A, De Hoog GS, et a1.Cerebral phaeohyphomycosis caused by Fonsecaea monophora[J].Med Mycol, 2005, 43(5):465-472. [7] Koo S, Klompas M, Marty FM. Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review[J].Med Mycol, 2010, 48(5):769-774. [8] Takei H, Goodman JC, Powell SZ.Cerebral phaeohyphomycosis caused by ladophialophora bantiana and Fonsecaea monophora: report of three cases[J]. Clin Neuropathol, 2007, 26(1):21-27. [9] Zhang J, Xi L, Lu C, et al. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China[J]. Mycoses, 2009, 52(2):176-181. [10] Zhang J, Xi LY, Zhang H, et al.Synergistic effects of terbinafine and itraconazole on clinical isolates of Fonsecaea monophora[J]. Eur J Dermatol. 2009, 19(5):451-455. [11] 刘红芳, 薛汝增, 黄进梅, 等.3 例着色芽生菌病的临床分析及病原菌鉴定[J]. 中国热带医学, 2010, 10(9):1062-1064. [12] 孙志坚, 李若瑜, 万喆, 等, 产孢丝状真菌药敏试验检测暗色真菌对九种药物的敏感性[J].中华皮肤科杂志, 2004, 37(4):197-199. |